Drill expectorant: description, use and side effects
Drill expectorant is a mucolytic drug that is used to treat diseases of the respiratory system with copious and viscous bronchial secretions, as well as for inflammatory diseases of the middle ear and paranasal sinuses. The drug is produced by the French company Pierre Fabre Medicine Production.
The active ingredient of the drug is carbocisteine. It improves loosening and discharge of sputum by changing its physicochemical properties. Drill expectorant is available in the form of 5% syrup and 750 mg chewable tablets.
The drug is contraindicated in case of hypersensitivity to carbocysteine, ulcerative lesions of the gastrointestinal tract, impaired renal function, acute glomerulonephritis, cystitis, pregnancy and breastfeeding, as well as for children under 1 year of age (for syrup) and children under 16 years of age (for tablets).
Side effects such as nausea, vomiting, epigastric pain, diarrhea, gastrointestinal bleeding, skin rash and angioedema may occur when using Drill expectorant.
The drug may also interact with other medicines. For example, it increases the effectiveness of glucocorticoid and antibacterial therapy for inflammatory diseases of the upper and lower respiratory tract, and also potentiates the bronchodilator effect of theophylline. Antitussives and atropine-like drugs may reduce the activity of carbocisteine.
In case of overdose, symptoms such as epigastric pain, nausea and diarrhea may occur. Treatment in this case should be symptomatic, since there is no specific antidote.
In general, Drill expectorant is an effective mucolytic drug that can help with diseases of the respiratory system with copious and viscous bronchial secretions. However, before using the drug, you should consult your doctor and read the instructions for use to avoid unwanted side effects and contraindications.